Galmed Pharmaceuticals (EOCN) Return on Equity [ROE] (2014 - 2026)
Galmed Pharmaceuticals' Return on Equity [ROE] came in at 61.81% for Q2 2026, up 53.31 percentage points from 8.50% a year earlier and up 49.98 percentage points from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Galmed Pharmaceuticals' Return on Equity [ROE] was 63.51%, up 13.99 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +13.45 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 49.52% in FY2024 (+1.02 pp), 48.50% in FY2023 and 481.99% in FY2021 (+431.93 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q2 2023.
- Year-over-year, Return on Equity [ROE] increased in two of the last six quarters, with an average year-over-year change of -12.92 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2021 (a gain of 858.49 percentage points), and the weakest in Q4 2022 (a drop of 790.42 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Galmed Pharmaceuticals | 2.06 Mn | -38.64 Mn | - | 61.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.81% |
| Mar 31, 2026 | 59.60% |
| Jun 30, 2025 | 46.47% |
| Mar 31, 2025 | 43.90% |
| Dec 31, 2024 | 43.03% |
| Sep 30, 2024 | 40.10% |
| Jun 30, 2024 | 46.09% |
| Mar 31, 2024 | 46.31% |
| Dec 31, 2023 | 2.64% |
| Sep 30, 2023 | 2.92% |
| Jun 30, 2023 | 98.40% |
| Mar 31, 2023 | 106.89% |
| Dec 31, 2022 | 2.16% |
| Sep 30, 2022 | 2.74% |
| Jun 30, 2022 | 115.95% |
| Mar 31, 2022 | 111.05% |
| Dec 31, 2021 | 96.55% |
| Sep 30, 2021 | 85.77% |
| Jun 30, 2021 | 71.20% |
| Mar 31, 2021 | 43.08% |
API Access
Galmed Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();